Bank of America’s Edesa Biotech EDSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-52
| Closed | -$74 | – | 6060 |
|
|
2025
Q4 | $74 | Buy |
52
+1
| +2% | +$2 | ﹤0.01% | 6882 |
|
|
2025
Q3 | $126 | Sell |
51
-3
| -6% | -$7 | ﹤0.01% | 7808 |
|
|
2025
Q2 | $109 | Buy |
54
+32
| +145% | +$68 | ﹤0.01% | 7953 |
|
|
2025
Q1 | $54 | Buy |
22
+3
| +16% | +$6 | ﹤0.01% | 7966 |
|
|
2024
Q4 | $32 | Hold |
19
| – | – | ﹤0.01% | 7938 |
|
|
2024
Q3 | $85 | Buy |
19
+1
| +6% | +$5 | ﹤0.01% | 7745 |
|
|
2024
Q2 | $77 | Buy |
+18
| New | +$80 | ﹤0.01% | 7760 |
|
|
2022
Q1 | – | Sell |
-2
| Closed | – | – | 8370 |
|
|
2021
Q4 | $0 | Buy |
+2
| New | +$96 | ﹤0.01% | 8315 |
|
|
2021
Q3 | – | Sell |
-7
| Closed | – | – | 8168 |
|
|
2021
Q2 | $0 | Buy |
+7
| New | +$284 | ﹤0.01% | 7820 |
|
|
2020
Q3 | – | Sell |
-2
| Closed | – | – | 6953 |
|
|
2020
Q2 | $0 | Sell |
2
-44
| -96% | -$991 | ﹤0.01% | 6899 |
|
|
2020
Q1 | $1K | Buy |
+46
| New | +$946 | ﹤0.01% | 6704 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | – | – | 7152 |
|
|
2019
Q3 | $0 | Buy |
+1
| New | +$36 | ﹤0.01% | 7303 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7175 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7167 |
|
|
2018
Q3 | – | Sell |
-2
| Closed | -$127 | – | 7307 |
|
|
2018
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 7129 |
|
|
2018
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7146 |
|
|
2017
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 7067 |
|
|
2017
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 6923 |
|
|
2017
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 6806 |
|
|
2017
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 6845 |
|
|
2016
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 6895 |
|
|
2016
Q3 | $1K | Sell |
2
-1
| -33% | -$839 | ﹤0.01% | 6923 |
|
|
2016
Q2 | $3K | Buy |
3
+1
| +50% | +$1.03K | ﹤0.01% | 6797 |
|
|
2016
Q1 | $2K | Hold |
2
| – | – | ﹤0.01% | 6770 |
|
|
2015
Q4 | $3K | Buy |
+2
| New | +$4.64K | ﹤0.01% | 7009 |
|
Other funds holding EDSA
VCIM
RCMNY
PA
VCM
VFT
SRL
Bank of America's EDSA Position: Q1 2026 in Review
Bank of America sold out of Edesa Biotech (EDSA) in Q1 2026, closing a stake of 52 shares — an estimated $74 sold.
Bank of America first reported a position in EDSA in Q4 2015 and held it in 23 quarters. The position peaked at $3K in Q2 2016. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.
- Bank of America reported no remaining Edesa Biotech position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 52 Edesa Biotech shares in Q1 2026, an estimated $74.
- Bank of America first reported a position in Edesa Biotech in Q4 2015 and held it in 23 quarters.
- Bank of America's Edesa Biotech position peaked at $3K in Q2 2016.
- 28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.